Abstract 735: HER2 protein quantification in multiple cancer indications identifies candidates for HER2 targeted therapies von Sellappan, Shankar, Schwartz, Sarit, Wertheimer, Ellen, Cecchi, Fabiola, Mamus, Steven W., Catenacci, Daniel VT, Hembrough, Todd

Volltext

Abstract 209: Proteomic analysis of therapeutic biomarkers in decalcified bone metastases von Cecchi, Fabiola, Sellappan, Shankar, Schwartz, Sarit, Gong, Chao, Darfler, Marlene, Scott, Kerry, Mamus, Steven W., Emmert-Buck, Mike, Hembrough, Todd

Volltext

Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with untreated or imatinib mesylate-resistant chronic myelogenous leukemia in blastic phase von Giles, Francis J., Feldman, Eric J., Roboz, Gail J., Larson, Richard A., Mamus, Steven W., Cortes, Jorge E., Verstovsek, Srdan, Faderl, Stefan, Talpaz, Moshe, Beran, Miloslav, Albitar, Maher, O’Brien, Susan M., Kantarjian, Hagop M.

Volltext

Ibuprofen-Associated Pure White-Cell Aplasia von Mamus, Steven W, Burton, Jack D, Groat, Jerome D, Schulte, Daniel A, Lobell, Michael, Zanjani, Esmail D

Volltext

CIMETIDINE-INDUCED REMISSION OF MYCOSIS FUNGOIDES von Mamus, StevenW, Mladenovic, Jeanette, Hordinsky, MariaK, Dahl, MarkV, Kay, NeilE

Volltext